Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,840.66
+32.681.81%
Number of Gainers:12
Number of Losers:6
Number of Flat:1
PE:- -
High:1,846.22
Open:1,807.96
Low:1,807.96
Close:1,807.97
Volume:52.04M
Turnover:4.13B
Market Cap:1.50T
Float Cap:1.46T

Loading ...

Pfizer Gets FDA Approval for Expanded Use of Breast-Cancer Treatment Tukysa

Dow Jones
·
1 hour ago

Pfizer announces FDA approval of TUKYSA regimen for HER2+ breast cancer

TIPRANKS
·
1 hour ago

Pfizer’s Tukysa Regimen Receives FDA Approval as Front-Line Maintenance Treatment for Her2+ Metastatic Breast Cancer

THOMSON REUTERS
·
2 hours ago

Moderna, Merck Climb on Collaboration with Tempus

Reuters
·
2 hours ago

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
2 hours ago

Moderna Price Target Raised to $95.00/Share from $89.00 by Morgan Stanley

Dow Jones
·
Yesterday

BioNTech Price Target Cut to $114.00/Share from $115.00 by Morgan Stanley

Dow Jones
·
Yesterday

Vir Biotechnology Price Target Raised to $22.00/Share from $20.00 by HC Wainwright & Co.

Dow Jones
·
Yesterday

Pfizer to Cut Around 330 Jobs in Italy

Reuters
·
Yesterday

Vir Biotechnology, Inc. : H.c. Wainwright Raises Target Price to $22 from $20

THOMSON REUTERS
·
Yesterday

AstraZeneca's Research Engine is Still Humming

Dow Jones
·
Yesterday

Morgan Stanley Adjusts Price Target on Moderna to $95 From $89

MT Newswires Live
·
Yesterday

Co-Diagnostics to Join Utah Global Health Leadership Roundtable on Vector Smart Mosquito Surveillance

Reuters
·
Yesterday

Tempus AI announces multi-year collaboration with Moderna, Merck

TIPRANKS
·
Yesterday

Vaccinex Says Neoadjuvant Melanoma Pilot Study Links Pepinemab Regimens to Immune Remodeling, Longer Recurrence-Free Survival

Reuters
·
Yesterday

Tempus Expands Multi-Year Collaboration with Moderna, Merck on V940 Melanoma Vaccine Commercialization Support

Reuters
·
Yesterday

Vir Biotechnology Appoints David Liu as Chief Medical Officer

THOMSON REUTERS
·
Yesterday

Tempus Announces Multi-Year Collaboration with Moderna and Merck

THOMSON REUTERS
·
Yesterday

J.P. Morgan Remains a Buy on Gilead Sciences (GILD)

TIPRANKS
·
Yesterday

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Yesterday